The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Norbexi Industries Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Norbexi Industries Ltd (formerly GB Hospitality India Pvt Ltd), a non-promoter entity, has sold its entire 14.46% stake (20,75,000 shares) in Bacil Pharma Ltd through an off-market transaction on February 19, 2026. Before the sale, Norbexi held 20,75,000 shares representing 14.46% of the company; after the sale, their holding is reduced to zero. Bacil Pharma's total equity share capital remains unchanged at 1,45,53,000 shares of Rs. 10 each. The acquirer is confirmed to not belong to the promoter or promoter group.
This represents a complete exit by a significant non-promoter shareholder via off-market route. While it doesn't affect promoter control, the change in shareholder base may influence trading sentiment. Retail investors should monitor for any subsequent disclosures indicating changes in control or promoter holdings.